Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NeoGenomics, Inc. (NEO)
USD14.08
-0.03 (-0.25%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
9490 NeoGenomics Way 33912
Fort Myers, FL, US
Fort Myers, FL, US
CEO
Anthony Zook
Website
neogenomics.com
IPO
2004-03-16
CIK 1077183 ISIN US64049M2098
Description
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease; fluorescence in-situ hybridization (FISH) for detecting and pinpointing specific DNA sequences and genes on chromosomes; and flow cytometry, used to measure cell population characteristics. Additionally, the company provides immunohistochemistry and digital imaging services, enabling the localization of cellular proteins in tissue sections, visualization of scanned slides, and quantitative analysis. Molecular testing, focusing on DNA/RNA analysis and gene structure/function, is also a key offering, alongside morphologic analysis where pathologists microscopically diagnose cells. Beyond clinical diagnostics, NeoGenomics supports pharmaceutical clients' oncology programs from discovery to commercialization and acts as a reference laboratory for anatomic pathology testing. The company, founded in 2001 and headquartered in Fort Myers, Florida, also maintains a strategic alliance and laboratory services agreement with Inivata Limited.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD14.08
-0.03 (-0.25%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
1.81
Float Shares
23.64M
Free Float %
90.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.79% | +1.36% | +34.99% | +41.50% | -5.91% | -5.19% | +57.71% | -31.47% | -74.41% | +37.15% | +2,493.02% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (29 ratings, all time)
Buy
Price Targets & DCF
Current price
14.08
Low
13.00
-7.6%
Consensus
19.00
+35.0%
Median
19.00
+35.0%
High
25.00
+77.6%
Ratings Trend (MoM)
67% Bullish
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 4 | -2 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
25.00
+77.6%
|
| Last Year | 7 |
12.86
-8.6%
|
| All Time | 19 |
19.74
+40.2%
|
Quality scores
Altman Z-Score
0.44
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+10.1% ★ Q1'26: +11.1% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%-35.5% Q1'26: +35.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-13.7% Q1'26: -7.0% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-14.6% Q1'26: -9.1% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-9.3% Q1'26: -6.1% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+1.1% Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-12.21× Q1'26: -180.13× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2010 actual |
Dec 2012 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 7 EPS Ana. |
Dec 2027 9 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 4 EPS Ana. |
Dec 2029 5 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
34.37M
est: 34.49M (-0.3%)
|
59.87M
est: 77.04M (-22.3%)
|
99.80M
est: 99.68M (+0.1%)
|
244.08M
est: 245.20M (-0.5%)
|
240.25M
est: 257.12M (-6.6%)
|
276.74M
est: 271.53M (+1.9%)
|
408.83M
est: 406.23M (+0.6%)
|
444.45M
est: 443.80M (+0.1%)
|
484.33M
est: 484.65M (-0.1%)
|
509.73M
est: 501.06M (+1.7%)
|
591.64M
est: 628.25M (-5.8%)
|
660.57M
est: 661.86M (-0.2%)
|
727.33M
est: 725.65M (+0.2%)
|
800.47M
799.97M – 800.87M
+10.3% YoY
|
880.67M
875.06M – 885.07M
+10.0% YoY
|
964.63M
964.62M – 964.63M
+9.5% YoY
|
1.04B
1.03B – 1.04B
+7.5% YoY
|
1.12B
1.11B – 1.12B
+8.0% YoY
|
| EBITDA |
-1.18M
est: -1.23M (+4.3%)
|
5.03M
est: 5.64M (-10.9%)
|
3.51M
est: -4.99M (+170.3%)
|
25.36M
est: 29.03M (-12.6%)
|
26.55M
est: 20.64M (+28.7%)
|
31.79M
est: 21.77M (+46.0%)
|
37.63M
est: 31.35M (+20.0%)
|
34.85M
est: 21.05M (+65.5%)
|
46.50M
est: 25.94M (+79.3%)
|
-82.33M
est: -126.99M (+35.2%)
|
-17.61M
est: -18.94M (+7.1%)
|
-1.51M
est: -19.96M (+92.4%)
|
-38.69M
est: -21.88M (-76.8%)
|
-24.14M
-24.15M – -24.12M
-10.3% YoY
|
-26.55M
-26.69M – -26.38M
-10.0% YoY
|
-29.09M
-29.09M – -29.09M
-9.5% YoY
|
-31.26M
-31.36M – -31.12M
-7.5% YoY
|
-33.76M
-33.87M – -33.61M
-8.0% YoY
|
| EBIT |
-2.96M
est: -2.80M (-5.8%)
|
1.21M
est: 1.55M (-21.9%)
|
-3.64M
est: -16.41M (+77.9%)
|
2.16M
est: 4.28M (-49.7%)
|
3.96M
est: -412.5K (+1,060.1%)
|
10.04M
est: 6.68M (+50.3%)
|
7.36M
est: 10.96M (-32.9%)
|
-7.04M
est: -34.59M (+79.7%)
|
-6.86M
est: -189.74M (+96.4%)
|
-151.76M
est: -195.11M (+22.2%)
|
-90.19M
est: -90.83M (+0.7%)
|
-74.06M
est: -95.69M (+22.6%)
|
-106.52M
est: -104.91M (-1.5%)
|
-115.73M
-115.79M – -115.66M
-10.3% YoY
|
-127.32M
-127.96M – -126.51M
-10.0% YoY
|
-139.46M
-139.46M – -139.46M
-9.5% YoY
|
-149.87M
-150.38M – -149.22M
-7.5% YoY
|
-161.85M
-162.41M – -161.15M
-8.0% YoY
|
| Net Income |
-3.30M
est: -2.99M (-10.3%)
|
65.0K
est: 95.6K (-32.0%)
|
-2.54M
est: -108.6K (-2,234.9%)
|
-6.14M
est: -4.33M (-41.7%)
|
-396.0K
est: -3.85M (+89.7%)
|
2.64M
est: 1.54M (+71.5%)
|
8.01M
est: 6.17M (+29.8%)
|
4.17M
est: -15.11M (+127.6%)
|
-8.35M
est: -77.40M (+89.2%)
|
-144.25M
est: -114.67M (-25.8%)
|
-87.97M
est: -15.96M (-451.3%)
|
-78.73M
est: 2.66M (-3,063.5%)
|
-108.03M
est: 2.53M (-4,366.5%)
|
4.48M
3.80M – 5.15M
+76.8% YoY
|
9.61M
8.52M – 10.71M
+114.8% YoY
|
10.81M
-5.82M – 27.43M
+12.4% YoY
|
15.88M
15.79M – 15.96M
+47.0% YoY
|
21.01M
20.89M – 21.10M
+32.3% YoY
|
| SGA |
18.75M
est: 18.19M (+3.1%)
|
23.34M
est: 29.39M (-20.6%)
|
45.19M
est: 49.96M (-9.5%)
|
87.84M
est: 105.75M (-16.9%)
|
113.30M
est: 107.08M (+5.8%)
|
114.22M
est: 79.78M (+43.2%)
|
175.34M
est: 147.92M (+18.5%)
|
191.66M
est: 263.78M (-27.3%)
|
283.94M
est: 242.90M (+16.9%)
|
277.91M
est: 355.14M (-21.7%)
|
279.96M
est: 323.80M (-13.5%)
|
310.49M
est: 341.12M (-9.0%)
|
365.34M
est: 374.00M (-2.3%)
|
412.56M
412.30M – 412.77M
+10.3% YoY
|
453.90M
451.01M – 456.17M
+10.0% YoY
|
497.17M
497.16M – 497.17M
+9.5% YoY
|
534.26M
531.94M – 536.09M
+7.5% YoY
|
576.99M
574.48M – 578.96M
+8.0% YoY
|
| EPS |
-0.44
est: -0.07 (-576.9%)
|
0.01
est: 0.01 (-30.0%)
|
-0.21
est: 0.00 (-4,799.7%)
|
-0.39
est: 0.14 (-386.8%)
|
-0.03
est: 0.12 (-121.0%)
|
0.14
est: 0.18 (-22.7%)
|
0.40
est: 0.28 (+44.3%)
|
0.19
est: 0.07 (+164.9%)
|
-0.35
est: -0.27 (-30.6%)
|
-5.80
est: -0.68 (-748.5%)
|
-3.50
est: -0.62 (-461.6%)
|
-3.10
est: 0.10 (-3,255.8%)
|
-4.20
est: 0.09 (-4,586.0%)
|
0.18
0.15 – 0.20
+92.3% YoY
|
0.36
0.33 – 0.42
+102.5% YoY
|
0.50
-0.23 – 1.07
+38.0% YoY
|
0.62
0.62 – 0.62
+23.3% YoY
|
0.82
0.82 – 0.82
+32.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-29 | TD Cowen | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-10 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-09 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
17.49M
OE per share TTM
0.14
Owner's Yield
6.07%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
30.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
260
Total invested
995.10M
Insider transactions (90d)
15
Beneficial owners (>5%)
32
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 19.33M | 15.70% | 19.06M | — | 19.33M | — | HC | Delaware | 2022-01-26 | ↗ |
| 2 | First Light Asset Management, LLC | 13.63M | 10.47% | 13.63M | 13.63M | 13.63M | — | IA | DELAWARE | 2026-05-07 | ↗ |
| 3 | Wellington Group Holdings LLP | 11.07M | 8.99% | — | 9.95M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 4 | Wellington Investment Advisors Holdings LLP | 11.07M | 8.99% | — | 9.95M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 5 | Wellington Management Group LLP | 11.07M | 8.99% | — | 9.95M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 10.43M | 10.04% | 204.1K | 16.8K | 10.22M | 210.8K | IA | Pennsylvania | 2019-10-10 | ↗ |
| 7 | Wellington Management Company LLP | 10.36M | 8.41% | — | 9.82M | — | — | IA | Massachusetts | 2022-02-04 | ↗ |
| 8 | Greenhouse Funds LLLP | 9.22M | 7.10% | 9.22M | 9.22M | 9.22M | — | IA, OO | DELAWARE | 2026-05-15 | ↗ |
| 9 | Artisan Investments GP LLC | 7.73M | 6.30% | — | 6.96M | — | 7.73M | HC | Delaware | 2022-02-04 | ↗ |
| 10 | Artisan Partners Asset Management Inc. | 7.73M | 6.30% | — | 6.96M | — | 7.73M | HC | Delaware | 2022-02-04 | ↗ |
| 11 | Artisan Partners Holdings LP | 7.73M | 6.30% | — | 6.96M | — | 7.73M | HC | Delaware | 2022-02-04 | ↗ |
| 12 | Artisan Partners Limited Partnership | 7.73M | 6.30% | — | 6.96M | — | 7.73M | IA | Delaware | 2022-02-04 | ↗ |
| 13 | Vanguard Portfolio Management | 7.68M | 5.91% | — | — | — | — | IA | PENNSYLVANIA | 2026-04-29 | ↗ |
| 14 | Vanguard Capital Management | 6.61M | 5.09% | — | — | — | — | IA | PENNSYLVANIA | 2026-04-30 | ↗ |
| 15 | Janus Henderson Group plc | 6.60M | 5.20% | — | 6.60M | — | 6.60M | IA, HC | Jersey, Channel Islands | 2024-11-14 | ↗ |
| 16 | 85-4328500 | 6.38M | 5.00% | 1.91M | — | 6.38M | — | IA | Maryland | 2024-02-14 | ↗ |
| 17 | Brown Advisory Incorporated ("BAI") | 6.34M | 5.00% | 5.50M | — | — | — | HC | Brown Advisory Incorporated is a Maryland Corporation. | 2023-02-09 | ↗ |
| 18 | Brown Advisory LLC (BALLC) | 6.30M | 5.00% | 5.47M | — | — | — | IA | Brown Advisory LLC is a Maryland Limited Liability Corporation. | 2023-02-09 | ↗ |
| 19 | Kinderhook, LP | 4.85M | 10.71% | — | 4.85M | — | 4.85M | PN | Delaware | 2013-02-12 | ↗ |
| 20 | 59-3792751 | 4.20M | 9.29% | 490.6K | 3.71M | 490.6K | 3.71M | IA | Delaware | 2013-02-14 | ↗ |
| 21 | Carl M. Wiese | 3.79M | 7.70% | — | 3.79M | — | — | HC, IN | USA | 2014-02-04 | ↗ |
| 22 | GROW Partners, LLC | 3.79M | 7.70% | — | 3.79M | — | — | IA, OO | Delaware | 2014-02-04 | ↗ |
| 23 | GROW Small Cap Equity Long/Short, LP | 3.79M | 7.70% | — | 3.79M | — | — | PN | Delaware | 2014-02-04 | ↗ |
| 24 | Iron Road Capital Partners, LLC 20-4493541 | 3.71M | 8.20% | — | 3.71M | — | 3.71M | OO | Delaware | 2013-02-14 | ↗ |
| 25 | Kopp Family Office, LLC | 3.60M | 4.50% | — | 3.60M | — | 3.60M | OO | Minnesota USA | 2018-07-05 | ↗ |
| 26 | T. Rowe Price Investment Management, Inc. | 3.32M | 2.60% | — | — | — | — | IA | MARYLAND | 2025-05-14 | ↗ |
| 27 | Integrated Core Strategies (US) LLC | 2.87M | 2.20% | 2.87M | 2.87M | 2.87M | — | OO | DELAWARE | 2025-07-17 | ↗ |
| 28 | Mathew P. Arens | 2.57M | 3.30% | — | 2.57M | — | — | IN | United State of America | 2017-02-14 | ↗ |
| 29 | 56-2450074 | 2.47M | 5.05% | 1.78M | — | 2.47M | — | IA | Wisconsin | 2014-01-09 | ↗ |
| 30 | Millennium Management LLC | 2.22M | 1.70% | 2.22M | 2.22M | 2.22M | — | OO | DELAWARE | 2026-05-13 | ↗ |
| 31 | Brown Investment Advisory & Trust Company ("BIATC") | 33.6K | 0.00% | 33.6K | — | — | — | BK | Brown Investment Advisory & Trust Company is a Maryland Trust Company. | 2023-02-09 | ↗ |
| 32 | SAMUEL R. SHAPIRO | — | 0.00% | — | 5.57M | — | 5.57M | IN | Jersey, Channel Islands | 2018-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
260
-4 vs prev Q
New positions
40
Closed positions
45
Increased
118
Reduced
86
Put/Call ratio
0.10
Calls held
834.3K
Puts held
85.7K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 19.96M +496.2K (+2.5%) | 148.08M -80.8M (-35.3%) | 77.57% +1.605 pp | 0.00% -0.001 pp | USD14.57 -49.1% | 7 qtrs — |
| 2 | FIRST LIGHT ASSET MANAGEMENT, LLC | 9.73M -305.1K (-3.0%) | 72.20M -45.8M (-38.8%) | 37.82% -1.409 pp | 6.47% -2.553 pp | USD10.38 -28.5% | 50 qtrs — |
| 3 | FIRST TRUST ADVISORS LP | 6.16M +6.2M (+100.0%) | 45.72M +45.7M (+100.0%) | 23.95% +23.951 pp | 0.03% +0.033 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 4 | — | 5.66M +5.7M (+100.0%) | 41.97M +42.0M (+100.0%) | 21.98% +21.982 pp | 0.00% +0.001 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 5 | BRAIDWELL LP | 5.62M +984.6K (+21.3%) | 41.68M -12.8M (-23.5%) | 21.83% +3.750 pp | 1.39% -0.352 pp | USD9.73 -23.7% | 3 qtrs — |
| 6 | STATE STREET CORP | 5.12M +141.5K (+2.8%) | 37.99M -20.6M (-35.1%) | 19.90% +0.468 pp | 0.00% -0.001 pp | USD18.62 -60.2% | 52 qtrs — |
| 7 | D. E. SHAW & CO., INC. | 4.16M -1.1M (-21.4%) | 30.90M -31.4M (-50.4%) | 16.18% -4.523 pp | 0.02% -0.016 pp | USD9.17 -19.1% | 17 qtrs — |
| 8 | SCHRODER INVESTMENT MANAGEMENT GROUP | 3.57M -449.0K (-11.2%) | 25.69M -23.4M (-47.7%) | 13.87% -1.812 pp | 0.02% -0.017 pp | USD18.34 -59.5% | 19 qtrs — |
| 9 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 3.45M -486.6K (-12.4%) | 25.62M -20.7M (-44.7%) | 13.42% -1.956 pp | 0.04% -0.026 pp | USD11.76 -36.9% | 2 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 3.23M +54.4K (+1.7%) | 23.98M -13.4M (-35.8%) | 12.56% +0.159 pp | 0.00% -0.001 pp | USD18.82 -60.6% | 54 qtrs — |
| 11 | BANK OF AMERICA CORP /DE/ | 3.05M +1.7M (+126.6%) | 22.66M +6.8M (+43.0%) | 11.87% +6.610 pp | 0.00% +0.001 pp | USD13.16 -43.6% | 53 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.67M +225.6K (+9.2%) | 19.84M -9.0M (-31.1%) | 10.39% +0.822 pp | 0.00% -0.002 pp | USD14.97 -50.4% | 38 qtrs — |
| 13 | SAMLYN CAPITAL, LLC | 2.56M +1.2M (+84.2%) | 18.98M +2.7M (+16.2%) | 9.94% +4.513 pp | 0.32% +0.064 pp | USD9.78 -24.1% | 2 qtrs — |
| 14 | AMERICAN CAPITAL MANAGEMENT INC | 2.25M -73.5K (-3.2%) | 16.70M -10.6M (-38.9%) | 8.75% -0.324 pp | 0.90% -0.309 pp | USD7.61 -2.5% | 5 qtrs — |
| 15 | MILLENNIUM MANAGEMENT LLC | 2.22M -3.0M (-57.3%) | 16.49M -44.7M (-73.1%) | 8.64% -11.675 pp | 0.01% -0.019 pp | USD9.52 -22.1% | 7 qtrs — |
| 16 | GW&K INVESTMENT MANAGEMENT, LLC | 2.19M -48.0K (-2.1%) | 16.26M -10.1M (-38.3%) | 8.51% -0.236 pp | 0.14% -0.084 pp | USD7.83 -5.2% | 15 qtrs — |
| 17 | MORGAN STANLEY | 2.16M +36.7K (+1.7%) | 16.05M -9.0M (-35.8%) | 8.41% +0.096 pp | 0.00% -0.001 pp | USD13.60 -45.4% | 52 qtrs — |
| 18 | ABRDN PLC | 2.03M +228.0K (+12.7%) | 15.04M -6.1M (-28.9%) | 7.88% +0.846 pp | 0.02% -0.009 pp | USD10.05 -26.2% | 5 qtrs — |
| 19 | LOOMIS SAYLES & CO L P | 1.95M +314.3K (+19.3%) | 14.43M -4.7M (-24.7%) | 7.56% +1.185 pp | 0.02% -0.004 pp | USD11.06 -32.9% | 2 qtrs — |
| 20 | PFM HEALTH SCIENCES, LP | 1.78M +90.5K (+5.3%) | 13.24M -6.7M (-33.5%) | 6.94% +0.324 pp | 1.21% -0.779 pp | USD8.12 -8.6% | 5 qtrs — |
| 21 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.72M -750.0K (-30.3%) | 12.78M -16.3M (-56.0%) | 6.69% -2.956 pp | 0.09% -0.104 pp | USD11.76 -36.9% | 2 qtrs — |
| 22 | NORTHERN TRUST CORP | 1.58M +157.7K (+11.1%) | 11.73M -5.0M (-29.9%) | 6.14% +0.582 pp | 0.00% -0.001 pp | USD12.47 -40.5% | 52 qtrs — |
| 23 | GLENMEDE TRUST CO NA | 1.30M -113.7K (-8.1%) | 9.63M -7.0M (-42.0%) | 5.04% -0.465 pp | 0.05% -0.031 pp | USD11.76 -36.9% | 2 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.19M -29.4K (-2.4%) | 8.81M -5.5M (-38.4%) | 4.62% -0.141 pp | 0.00% -0.001 pp | USD17.64 -57.9% | 44 qtrs — |
| 25 | SEGALL BRYANT & HAMILL, LLC | 1.13M -599.0K (-34.6%) | 8.41M -12.0M (-58.7%) | 4.40% -2.357 pp | 0.10% -0.171 pp | USD12.17 -39.0% | 15 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 1.00M -429.5K (-30.0%) | 7.45M -9.4M (-55.8%) | 3.90% -1.701 pp | 0.00% -0.001 pp | USD11.15 -33.5% | 40 qtrs — |
| 27 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 938.1K +60.1K (+6.8%) | 6.96M -3.4M (-32.6%) | 3.65% +0.214 pp | 0.02% -0.011 pp | USD9.04 -17.9% | 4 qtrs — |
| 28 | VANGUARD FIDUCIARY TRUST CO | 847.3K +847.3K (+100.0%) | 6.29M +6.3M (+100.0%) | 3.29% +3.293 pp | 0.00% +0.002 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 29 | GRANITE INVESTMENT PARTNERS, LLC | 752.5K +752.5K (+100.0%) | 5.58M +5.6M (+100.0%) | 2.92% +2.925 pp | 0.34% +0.343 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 30 | BANK OF NEW YORK MELLON CORP | 714.4K -25.7K (-3.5%) | 5.30M -3.4M (-39.1%) | 2.78% -0.116 pp | 0.00% -0.001 pp | USD16.38 -54.7% | 52 qtrs — |
| 31 | FRED ALGER MANAGEMENT, LLC | 651.6K +651.6K (+100.0%) | 4.84M +4.8M (+100.0%) | 2.53% +2.533 pp | 0.02% +0.021 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 32 | PRINCIPAL FINANCIAL GROUP INC | 629.3K +12.4K (+2.0%) | 4.67M -2.6M (-35.6%) | 2.45% +0.034 pp | 0.00% -0.001 pp | USD22.09 -66.4% | 31 qtrs — |
| 33 | CITIGROUP INC | 616.8K +585.7K (+1,881.9%) | 4.58M +4.2M (+1,150.5%) | 2.40% +2.276 pp | 0.00% +0.002 pp | USD7.70 -3.6% | 44 qtrs — |
| 34 | JPMORGAN CHASE & CO | 605.7K +21.6K (+3.7%) | 4.36M -2.5M (-36.5%) | 2.35% +0.071 pp | 0.00% 0.000 pp | USD9.47 -21.6% | 34 qtrs — |
| 35 | HIGHMARK WEALTH MANAGEMENT LLC | 579.8K +12.5K (+2.2%) | 4.30M -2.4M (-35.5%) | 2.25% +0.036 pp | 1.75% -0.967 pp | USD10.04 -26.1% | 24 qtrs — |
| 36 | INVESCO LTD. | 562.5K +23.3K (+4.3%) | 4.17M -2.2M (-34.2%) | 2.19% +0.082 pp | 0.00% 0.000 pp | USD16.88 -56.0% | 36 qtrs — |
| 37 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 544.7K -28.6K (-5.0%) | 4.04M -2.7M (-40.1%) | 2.12% -0.121 pp | 0.00% 0.000 pp | USD12.39 -40.1% | 25 qtrs — |
| 38 | SEI INVESTMENTS CO | 466.2K +355.4K (+320.7%) | 3.46M +2.2M (+165.4%) | 1.81% +1.379 pp | 0.00% +0.002 pp | USD9.53 -22.1% | 43 qtrs — |
| 39 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 462.9K +15.2K (+3.4%) | 3.43M -1.8M (-34.8%) | 1.80% +0.052 pp | 0.01% -0.007 pp | USD14.89 -50.2% | 29 qtrs — |
| 40 | NUVEEN, LLC | 419.5K -4.1K (-1.0%) | 3.11M -1.9M (-37.5%) | 1.63% -0.023 pp | 0.00% -0.001 pp | USD8.54 -13.1% | 5 qtrs — |
| 41 | RHUMBLINE ADVISERS | 364.0K +6.8K (+1.9%) | 2.70M -1.5M (-35.7%) | 1.41% +0.020 pp | 0.00% -0.001 pp | USD16.68 -55.5% | 44 qtrs — |
| 42 | UBS ASSET MANAGEMENT AMERICAS INC | 359.9K +9.1K (+2.6%) | 2.67M -1.5M (-35.3%) | 1.40% +0.027 pp | 0.00% 0.000 pp | USD14.61 -49.2% | 32 qtrs — |
| 43 | CAMPBELL & CO INVESTMENT ADVISER LLC | 350.9K +350.9K (+100.0%) | 2.60M +2.6M (+100.0%) | 1.36% +1.364 pp | 0.15% +0.148 pp | USD7.42 +0.0% | 7 qtrs — |
| 44 | AMERIPRISE FINANCIAL INC | 337.4K -88.8K (-20.8%) | 2.50M -2.5M (-50.1%) | 1.31% -0.355 pp | 0.00% -0.001 pp | USD21.65 -65.7% | 32 qtrs — |
| 45 | SAMJO MANAGEMENT, LLC | 316.7K +31.4K (+11.0%) | 2.35M -1.0M (-30.0%) | 1.23% +0.117 pp | 1.02% -0.281 pp | USD9.09 -18.4% | 5 qtrs — |
| 46 | SG AMERICAS SECURITIES, LLC | 312.2K -2.2K (-0.7%) | 2.32M -1.4M (-37.4%) | 1.21% -0.016 pp | 0.00% -0.002 pp | USD10.99 -32.5% | 4 qtrs — |
| 47 | LEGAL & GENERAL GROUP PLC | 295.2K -29.0K (-9.0%) | 2.19M -1.6M (-42.6%) | 1.15% -0.120 pp | 0.00% 0.000 pp | USD27.67 -73.2% | 41 qtrs — |
| 48 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 275.8K -318.0K (-53.6%) | 2.05M -4.9M (-70.7%) | 1.07% -1.246 pp | 0.01% -0.016 pp | USD7.37 +0.7% | 4 qtrs — |
| 49 | STATE OF WISCONSIN INVESTMENT BOARD | 266.3K -4.3K (-1.6%) | 1.98M -1.2M (-37.9%) | 1.04% -0.023 pp | 0.00% -0.003 pp | USD16.22 -54.3% | 19 qtrs — |
| 50 | VOYA INVESTMENT MANAGEMENT LLC | 255.5K -29.4K (-10.3%) | 1.90M -1.5M (-43.4%) | 0.99% -0.121 pp | 0.00% -0.001 pp | USD12.09 -38.6% | 44 qtrs — |
| 51 | SWISS NATIONAL BANK | 254.7K +— (+0.0%) | 1.89M -1.1M (-36.9%) | 0.99% -0.006 pp | 0.00% -0.001 pp | USD16.89 -56.1% | 40 qtrs — |
| 52 | RENAISSANCE TECHNOLOGIES LLC | 254.2K +254.2K (+100.0%) | 1.89M +1.9M (+100.0%) | 0.99% +0.988 pp | 0.00% +0.003 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 53 | ALLIANCEBERNSTEIN L.P. | 160.3K +4.1K (+2.6%) | 1.89M +48.1K (+2.6%) | 0.62% +0.013 pp | 0.00% +0.000 pp | USD22.65 -67.2% | 40 qtrs — |
| 54 | HARBOR CAPITAL ADVISORS, INC. | 243.6K +243.6K (+100.0%) | 1.81M +1.8M (+100.0%) | 0.95% +0.947 pp | 0.15% +0.146 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 55 | BULLSEYE ASSET MANAGEMENT LLC | 236.9K +— (+0.0%) | 1.76M -1.0M (-36.9%) | 0.92% -0.004 pp | 1.02% -0.483 pp | USD19.55 -62.0% | 26 qtrs — |
| 56 | FMR LLC | 226.3K +55.8K (+32.7%) | 1.68M -325.7K (-16.2%) | 0.88% +0.213 pp | 0.00% +0.000 pp | USD10.03 -26.0% | 29 qtrs — |
| 57 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 194.1K +70.3K (+56.8%) | 1.44M -15.4K (-1.1%) | 0.75% +0.271 pp | 0.00% +0.000 pp | USD12.12 -38.8% | 44 qtrs — |
| 58 | UBS GROUP AG | 190.5K -157.1K (-45.2%) | 1.41M -2.7M (-65.4%) | 0.74% -0.616 pp | 0.00% -0.001 pp | USD11.29 -34.3% | 46 qtrs — |
| 59 | SOLEUS CAPITAL MANAGEMENT, L.P. | 175.0K -252.5K (-59.1%) | 1.30M -3.7M (-74.2%) | 0.68% -0.991 pp | 0.05% -0.133 pp | USD11.76 -36.9% | 2 qtrs — |
| 60 | FEDERATED HERMES, INC. | 169.3K +5.1K (+3.1%) | 1.26M -674.4K (-34.9%) | 0.66% +0.016 pp | 0.00% -0.001 pp | USD13.59 -45.4% | 42 qtrs — |
| 61 | AQR CAPITAL MANAGEMENT LLC | 167.4K +21.0K (+14.4%) | 1.24M -479.3K (-27.8%) | 0.65% +0.078 pp | 0.00% 0.000 pp | USD9.60 -22.7% | 5 qtrs — |
| 62 | SILVERBACK ASSET MANAGEMENT LLC | 165.1K +— (+0.0%) | 1.23M -716.5K (-36.9%) | 0.64% -0.004 pp | 0.18% -0.109 pp | USD7.72 -3.9% | 3 qtrs — |
| 63 | PRICE T ROWE ASSOCIATES INC /MD/ | 156.1K +32.2K (+26.0%) | 1.16M -299.0K (-20.5%) | 0.61% +0.123 pp | 0.00% +0.000 pp | USD18.22 -59.3% | 37 qtrs — |
| 64 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 153.0K -8.6K (-5.3%) | 1.14M -765.0K (-40.3%) | 0.59% -0.037 pp | 0.00% -0.001 pp | USD17.96 -58.7% | 29 qtrs — |
| 65 | Y-INTERCEPT (HONG KONG) LTD | 139.8K +56.3K (+67.4%) | 1.04M +55.1K (+5.6%) | 0.54% +0.217 pp | 0.02% -0.002 pp | USD7.60 -2.4% | 3 qtrs — |
| 66 | PRUDENTIAL FINANCIAL INC | 136.5K +12.2K (+9.9%) | 1.01M -448.3K (-30.7%) | 0.53% +0.046 pp | 0.00% -0.001 pp | USD20.94 -64.6% | 31 qtrs — |
| 67 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 135.1K +2.2K (+1.6%) | 1.00M -560.6K (-35.9%) | 0.52% +0.006 pp | 0.00% -0.001 pp | USD9.27 -20.0% | 5 qtrs — |
| 68 | PERKINS CAPITAL MANAGEMENT INC | 132.4K -9.5K (-6.7%) | 982.0K -686.1K (-41.1%) | 0.51% -0.040 pp | 0.92% -0.404 pp | USD28.88 -74.3% | 23 qtrs — |
| 69 | WHITE PINE CAPITAL LLC | 128.9K -26.3K (-17.0%) | 956.1K -868.8K (-47.6%) | 0.50% -0.106 pp | 0.27% -0.233 pp | USD9.35 -20.6% | 10 qtrs — |
| 70 | AMERICAN CENTURY COMPANIES INC | 127.2K +56.0K (+78.5%) | 944.1K +105.8K (+12.6%) | 0.49% +0.216 pp | 0.00% +0.000 pp | USD10.33 -28.2% | 14 qtrs — |
| 71 | DEUTSCHE BANK AG\ | 118.0K +13.2K (+12.6%) | 875.5K -356.7K (-29.0%) | 0.46% +0.049 pp | 0.00% 0.000 pp | USD20.21 -63.3% | 51 qtrs — |
| 72 | GREENHOUSE FUNDS LLLP | 115.8K +115.8K (+100.0%) | 859.2K +859.2K (+100.0%) | 0.45% +0.450 pp | 0.04% +0.039 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 73 | BNP PARIBAS ARBITRAGE, SNC | 109.9K -3.1K (-2.7%) | 815.4K -513.1K (-38.6%) | 0.43% -0.014 pp | 0.00% 0.000 pp | USD8.02 -7.5% | 44 qtrs — |
| 74 | GABELLI FUNDS LLC | 109.5K -9.5K (-8.0%) | 812.5K -587.0K (-41.9%) | 0.43% -0.040 pp | 0.01% -0.004 pp | USD9.82 -24.4% | 9 qtrs — |
| 75 | FRANKLIN RESOURCES INC | 109.4K +23.7K (+27.7%) | 812.0K -195.7K (-19.4%) | 0.43% +0.090 pp | 0.00% +0.000 pp | USD11.78 -37.0% | 34 qtrs — |
| 76 | TWINBEECH CAPITAL LP | 106.3K +106.3K (+100.0%) | 788.7K +788.7K (+100.0%) | 0.41% +0.413 pp | 0.08% +0.082 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 77 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 106.1K +— (+0.0%) | 788.0K -459.0K (-36.8%) | 0.41% -0.002 pp | 0.00% -0.001 pp | USD19.84 -62.6% | 40 qtrs — |
| 78 | SQUAREPOINT OPS LLC | 101.7K +69.4K (+214.7%) | 754.6K +374.6K (+98.6%) | 0.40% +0.269 pp | 0.00% +0.001 pp | USD7.64 -2.9% | 17 qtrs — |
| 79 | GAMCO INVESTORS, INC. ET AL | 100.0K +84.0K (+525.0%) | 742.0K +553.8K (+294.3%) | 0.39% +0.326 pp | 0.01% +0.006 pp | USD7.42 +0.0% | 4 qtrs — |
| 80 | NEW YORK STATE COMMON RETIREMENT FUND | 99.9K +63.4K (+174.2%) | 741.1K +312.7K (+73.0%) | 0.39% +0.246 pp | 0.00% +0.001 pp | USD10.37 -28.4% | 47 qtrs — |
| 81 | BRIDGEWATER ASSOCIATES, LP | 91.2K +91.2K (+100.0%) | 676.6K +676.6K (+100.0%) | 0.35% +0.354 pp | 0.00% +0.003 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 82 | THRIVENT FINANCIAL FOR LUTHERANS | 86.4K -2.5K (-2.9%) | 641.0K -405.0K (-38.7%) | 0.34% -0.012 pp | 0.00% -0.001 pp | USD15.65 -52.6% | 29 qtrs — |
| 83 | RMB CAPITAL MANAGEMENT, LLC | 85.3K +2.0K (+2.4%) | 633.1K -347.1K (-35.4%) | 0.33% +0.006 pp | 0.01% -0.006 pp | USD7.31 +1.5% | 4 qtrs — |
| 84 | WELLS FARGO & COMPANY/MN | 80.3K -78.2K (-49.3%) | 595.7K -1.3M (-68.0%) | 0.31% -0.306 pp | 0.00% 0.000 pp | USD13.87 -46.5% | 48 qtrs — |
| 85 | VANGUARD ASSET MANAGEMENT, LTD | 78.9K +78.9K (+100.0%) | 585.1K +585.1K (+100.0%) | 0.31% +0.307 pp | 0.00% +0.001 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 86 | ILLINOIS MUNICIPAL RETIREMENT FUND | 75.8K +75.8K (+100.0%) | 562.3K +562.3K (+100.0%) | 0.29% +0.295 pp | 0.01% +0.007 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 87 | CITADEL ADVISORS LLC | 74.9K -134.5K (-64.2%) | 555.8K -1.9M (-77.4%) | 0.29% -0.526 pp | 0.00% 0.000 pp | USD12.43 -40.3% | 31 qtrs — |
| 88 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 71.4K -1.7K (-2.3%) | 529.0K -329.0K (-38.3%) | 0.28% -0.008 pp | 0.01% -0.003 pp | USD22.04 -66.3% | 29 qtrs — |
| 89 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 71.2K +25.8K (+56.9%) | 528.6K -5.4K (-1.0%) | 0.28% +0.099 pp | 0.00% +0.000 pp | USD13.17 -43.7% | 40 qtrs — |
| 90 | SCHONFELD STRATEGIC ADVISORS LLC | 69.4K +69.4K (+100.0%) | 514.8K +514.8K (+100.0%) | 0.27% +0.270 pp | 0.00% +0.004 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 91 | INSPIRE INVESTING, LLC | 69.2K +29.8K (+75.8%) | 513.4K +50.6K (+10.9%) | 0.27% +0.115 pp | 0.05% +0.008 pp | USD8.90 -16.6% | 11 qtrs — |
| 92 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 66.0K +48.5K (+275.7%) | 490.0K +283.3K (+137.1%) | 0.26% +0.188 pp | 0.00% +0.002 pp | USD8.58 -13.5% | 4 qtrs — |
| 93 | QUBE RESEARCH & TECHNOLOGIES LTD | 65.6K +65.6K (+100.0%) | 486.5K +486.5K (+100.0%) | 0.25% +0.255 pp | 0.00% +0.001 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 94 | METLIFE INVESTMENT MANAGEMENT, LLC | 65.3K -6.4K (-8.9%) | 484.6K -359.0K (-42.6%) | 0.25% -0.027 pp | 0.00% -0.002 pp | USD13.96 -46.8% | 34 qtrs — |
| 95 | ENVESTNET ASSET MANAGEMENT INC | 63.8K +63.8K (+100.0%) | 473.3K +473.3K (+100.0%) | 0.25% +0.248 pp | 0.00% +0.000 pp | USD7.42 +0.0% | 1 qtrs NEW |
| 96 | CREATIVE PLANNING | 60.6K +6.6K (+12.3%) | 449.6K -185.0K (-29.2%) | 0.24% +0.025 pp | 0.00% 0.000 pp | USD9.65 -23.1% | 23 qtrs — |
| 97 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 60.5K +608.0 (+1.0%) | 449.0K -255.5K (-36.3%) | 0.24% +0.001 pp | 0.00% 0.000 pp | USD13.82 -46.3% | 8 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.30
Neutral
Ratio by volume
1.35
Neutral
Buys
30
Sells
23
Shares acquired
562.8K
Shares disposed
416.1K
Cash buys
—
Cash sales
1.00
Net activity
+146,662
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | TETRAULT LYNN A. | Director | S-Sale | D | Common Stock | 5,307 | 11.29 | 59.9K | 91,422 | D | ↗ |
| 2026-06-01 | Williams Felicia | Director | A-Award | A | Stock Option (Right to Buy) | 11,069 | 10.52 | 116.4K | 11,069 | D | ↗ |
| 2026-06-01 | TETRAULT LYNN A. | Director | M-Exempt | A | Common Stock | 23,077 | 0.00 | — | 96,729 | D | ↗ |
| 2026-06-01 | Perez David Brian | Director | M-Exempt | D | Restricted Stock Unit | 23,077 | 0.00 | — | 0 | D | ↗ |
| 2026-06-01 | Kenny John P. | Director | A-Award | A | Restricted Stock Unit | 15,970 | 0.00 | — | 15,970 | D | ↗ |
| 2026-06-01 | Kelly Michael Aaron | Director | A-Award | A | Restricted Stock Unit | 15,970 | 0.00 | — | 15,970 | D | ↗ |
| 2026-06-01 | KANOVSKY STEPHEN M | Director | M-Exempt | A | Common Stock | 23,077 | 0.00 | — | 75,421 | D | ↗ |
| 2026-06-01 | Gunn Neil | Director | M-Exempt | A | Common Stock | 23,077 | 0.00 | — | 51,177 | D | ↗ |
| 2026-06-01 | Green Marjorie C | Director | M-Exempt | A | Common Stock | 22,964 | 0.00 | — | 22,964 | D | ↗ |
| 2026-05-11 | Stone Warren | Officer | M-Exempt | A | Common Stock | 5,830 | 0.00 | — | 167,815 | D | ↗ |
| 2026-05-11 | Olivo Alicia C | Officer | M-Exempt | A | Common Stock | 3,944 | 0.00 | — | 96,126 | D | ↗ |
| 2026-05-02 | Stone Warren | Officer | M-Exempt | D | Restricted Stock Unit | 5,969 | 0.00 | — | 11,939 | D | ↗ |
| 2026-05-02 | Aunan Greg D | Officer | M-Exempt | D | Restricted Stock Unit | 5,372 | 0.00 | — | 10,745 | D | ↗ |
| 2026-05-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 1,042 | 0.00 | — | 92,182 | D | ↗ |
| 2026-05-01 | Aunan Greg D | Officer | F-InKind | D | Common Stock | 937 | 0.00 | — | 21,090 | D | ↗ |
| 2026-04-01 | Zook Anthony P. | Director / Officer | M-Exempt | D | Restricted Stock Unit | 140,498 | 0.00 | — | 280,998 | D | ↗ |
| 2026-04-01 | Stone Warren | Officer | M-Exempt | A | Common Stock | 17,562 | 0.00 | — | 165,276 | D | ↗ |
| 2026-03-02 | Jain Abhishek | Officer | — | — | Stock Option (Right to Buy) | 183,578 | 13.74 | 2.52M | 0 | D | ↗ |
| 2026-03-01 | Zook Anthony P. | Director / Officer | A-Award | A | Restricted Stock Unit | 406,918 | 0.00 | — | 406,918 | D | ↗ |
| 2026-03-01 | Stone Warren | Officer | A-Award | A | Restricted Stock Unit | 152,594 | 0.00 | — | 152,594 | D | ↗ |
| 2026-03-01 | Olivo Alicia C | Officer | A-Award | A | Stock Option (Right to Buy) | 147,804 | 10.81 | 1.60M | 147,804 | D | ↗ |
| 2026-03-01 | Aunan Greg D | Officer | A-Award | A | Restricted Stock Unit | 22,889 | 0.00 | — | 22,889 | D | ↗ |
| 2026-02-23 | Stone Warren | Officer | F-InKind | D | Common Stock | 3,323 | 0.00 | — | 147,714 | D | ↗ |
| 2026-02-23 | Sherman Jeffrey Scott | Officer | M-Exempt | A | Common Stock | 15,535 | 0.00 | — | 223,792 | D | ↗ |
| 2026-02-23 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 3,323 | 0.00 | — | 93,224 | D | ↗ |
| 2026-02-21 | Stone Warren | Officer | M-Exempt | D | Restricted Stock Unit | 28,105 | 0.00 | — | 56,212 | D | ↗ |
| 2026-02-21 | Sherman Jeffrey Scott | Officer | M-Exempt | D | Restricted Stock Unit | 42,158 | 0.00 | — | 84,318 | D | ↗ |
| 2026-02-21 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 8,295 | 0.00 | — | 88,104 | D | ↗ |
| 2026-02-21 | Aunan Greg D | Officer | M-Exempt | D | Restricted Stock Unit | 6,323 | 0.00 | — | 12,648 | D | ↗ |
| 2026-01-20 | Stone Warren | Officer | S-Sale | D | Common Stock | 22,128 | 12.50 | 276.7K | 121,631 | D | ↗ |
| 2026-01-13 | Stone Warren | Officer | M-Exempt | A | Common Stock | 59,382 | 0.00 | — | 158,886 | D | ↗ |
| 2026-01-13 | Olivo Alicia C | Officer | M-Exempt | A | Common Stock | 59,382 | 0.00 | — | 90,465 | D | ↗ |
| 2026-01-01 | Kenny John P. | Director | A-Award | A | Stock Option (Right to Buy) | 4,171 | 11.76 | 49.1K | 4,171 | D | ↗ |
| 2025-12-07 | Sherman Jeffrey Scott | Officer | F-InKind | D | Common Stock | 11,938 | 0.00 | — | 176,394 | D | ↗ |
| 2025-12-01 | Stone Warren | Officer | F-InKind | D | Common Stock | 8,776 | 0.00 | — | 99,504 | D | ↗ |
| 2025-11-25 | Olivo Alicia C | Officer | M-Exempt | A | Common Stock | 8,977 | 10.05 | 90.2K | 51,999 | D | ↗ |
| 2025-09-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 1,666 | 0.00 | — | 47,940 | D | ↗ |
| 2025-08-06 | Zook Anthony P. | Director / Officer | P-Purchase | A | Common Stock | 17,900 | 5.58 | 100.0K | 38,066 | D | ↗ |
| 2025-08-06 | Sherman Jeffrey Scott | Officer | P-Purchase | A | Common Stock | 20,000 | 5.62 | 112.3K | 188,332 | D | ↗ |
| 2025-08-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 14 | 0.00 | — | 49,606 | D | ↗ |
| 2025-06-19 | Green Marjorie C | Director | A-Award | A | Restricted Stock Unit | 22,964 | 0.00 | — | 22,964 | D | ↗ |
| 2025-06-01 | Zook Anthony P. | Director / Officer | M-Exempt | A | Common Stock | 12,254 | 0.00 | — | 23,590 | D | ↗ |
| 2025-06-01 | Williams Felicia | Director | A-Award | A | Restricted Stock Unit | 23,077 | 0.00 | — | 23,077 | D | ↗ |
| 2025-06-01 | TETRAULT LYNN A. | Director | M-Exempt | D | Restricted Stock Unit | 12,254 | 0.00 | — | 0 | D | ↗ |
| 2025-06-01 | Perez David Brian | Director | A-Award | A | Stock Option (Right to Buy) | 16,107 | 7.28 | 117.3K | 16,107 | D | ↗ |
| 2025-06-01 | Kelly Michael Aaron | Director | A-Award | A | Restricted Stock Unit | 23,077 | 0.00 | — | 23,077 | D | ↗ |
| 2025-06-01 | KANOVSKY STEPHEN M | Director | A-Award | A | Stock Option (Right to Buy) | 16,107 | 7.28 | 117.3K | 16,107 | D | ↗ |
| 2025-06-01 | HANNAH ALISON L. | Director | A-Award | A | Stock Option (Right to Buy) | 16,107 | 7.28 | 117.3K | 16,107 | D | ↗ |
| 2025-06-01 | Gunn Neil | Director | A-Award | A | Restricted Stock Unit | 23,077 | 0.00 | — | 23,077 | D | ↗ |
| 2025-06-01 | Floegel Elizabeth | Director | M-Exempt | A | Common Stock | 12,254 | 0.00 | — | 23,590 | D | ↗ |
| 2025-05-27 | Kelly Michael Aaron | Director | P-Purchase | A | Common Stock | 5,000 | 7.60 | 38.0K | 5,000 | I | ↗ |
| 2025-05-12 | Stone Warren | Officer | P-Purchase | A | Common Stock | 5,700 | 8.58 | 48.9K | 108,280 | D | ↗ |
| 2025-05-11 | Stone Warren | Officer | F-InKind | D | Common Stock | 2,341 | 0.00 | — | 102,580 | D | ↗ |
| 2025-05-11 | Sherman Jeffrey Scott | Officer | F-InKind | D | Common Stock | 3,167 | 0.00 | — | 168,332 | D | ↗ |
| 2025-05-11 | Olivo Alicia C | Officer | M-Exempt | A | Common Stock | 6,503 | 0.00 | — | 51,204 | D | ↗ |
| 2025-05-09 | TETRAULT LYNN A. | Director | P-Purchase | A | Common Stock | 7,000 | 8.14 | 57.0K | 7,000 | I | ↗ |
| 2025-05-07 | KANOVSKY STEPHEN M | Director | P-Purchase | A | Common Stock | 4,000 | 7.78 | 31.1K | 40,090 | D | ↗ |
| 2025-05-06 | Zook Anthony P. | Director / Officer | P-Purchase | A | Common Stock | 18,900 | 7.88 | 148.9K | 18,900 | I | ↗ |
| 2025-05-05 | Perez David Brian | Director | P-Purchase | A | Common Stock | 10,000 | 7.63 | 76.3K | 10,000 | I | ↗ |
| 2025-05-05 | Gunn Neil | Director | P-Purchase | A | Common Stock | 4,510 | 7.76 | 35.0K | 15,846 | D | ↗ |
| 2025-05-02 | Stone Warren | Officer | M-Exempt | A | Common Stock | 5,969 | 0.00 | — | 96,762 | D | ↗ |
| 2025-05-02 | Sherman Jeffrey Scott | Officer | P-Purchase | A | Common Stock | 20,000 | 7.51 | 150.1K | 158,494 | D | ↗ |
| 2025-05-02 | Aunan Greg D | Officer | F-InKind | D | Common Stock | 1,309 | 0.00 | — | 17,579 | D | ↗ |
| 2025-05-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 652 | 0.00 | — | 44,701 | D | ↗ |
| 2025-05-01 | Aunan Greg D | Officer | F-InKind | D | Common Stock | 937 | 0.00 | — | 13,516 | D | ↗ |
| 2025-04-01 | Zook Anthony P. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 729,927 | 10.44 | 7.62M | 729,927 | D | ↗ |
| 2025-04-01 | Stone Warren | Officer | A-Award | A | Stock Option (Right to Buy) | 94,518 | 10.44 | 986.8K | 94,518 | D | ↗ |
| 2025-02-23 | Stone Warren | Officer | M-Exempt | D | Restricted Stock Unit | 8,443 | 0.00 | — | 16,886 | D | ↗ |
| 2025-02-23 | Smith Christopher M | Officer | M-Exempt | D | Restricted Stock Unit | 57,413 | 0.00 | — | 114,826 | D | ↗ |
| 2025-02-23 | Sherman Jeffrey Scott | Officer | F-InKind | D | Common Stock | 4,207 | 0.00 | — | 137,064 | D | ↗ |
| 2025-02-23 | Olivo Alicia C | Officer | M-Exempt | D | Restricted Stock Unit | 8,443 | 0.00 | — | 16,886 | D | ↗ |
| 2025-02-23 | Harris Melody | Officer | M-Exempt | D | Restricted Stock Unit | 8,443 | 0.00 | — | 16,886 | D | ↗ |
| 2025-02-21 | Stone Warren | Officer | A-Award | A | Restricted Stock Unit | 84,317 | 0.00 | — | 84,317 | D | ↗ |
| 2025-02-21 | Sherman Jeffrey Scott | Officer | A-Award | A | Restricted Stock Unit | 126,476 | 0.00 | — | 126,476 | D | ↗ |
| 2025-02-21 | Olivo Alicia C | Officer | A-Award | A | Restricted Stock Unit | 63,238 | 0.00 | — | 63,238 | D | ↗ |
| 2025-02-21 | Harris Melody | Officer | A-Award | A | Restricted Stock Unit | 84,317 | 0.00 | — | 84,317 | D | ↗ |
| 2025-02-21 | Aunan Greg D | Officer | A-Award | A | Restricted Stock Unit | 18,971 | 0.00 | — | 18,971 | D | ↗ |
| 2025-01-14 | Stone Warren | Officer | A-Award | A | Restricted Stock Unit | 59,382 | 0.00 | — | 59,382 | D | ↗ |
| 2025-01-14 | Sherman Jeffrey Scott | Officer | A-Award | A | Restricted Stock Unit | 59,382 | 0.00 | — | 59,382 | D | ↗ |
| 2025-01-14 | Olivo Alicia C | Officer | A-Award | A | Restricted Stock Unit | 59,382 | 0.00 | — | 59,382 | D | ↗ |
| 2025-01-14 | Harris Melody | Officer | A-Award | A | Restricted Stock Unit | 59,382 | 0.00 | — | 59,382 | D | ↗ |
| 2025-01-01 | Harris Melody | Officer | F-InKind | D | Common Stock | 7,070 | 0.00 | — | 102,820 | D | ↗ |
| 2024-12-07 | Sherman Jeffrey Scott | Officer | F-InKind | D | Common Stock | 11,746 | 0.00 | — | 123,754 | D | ↗ |
| 2024-12-01 | Stone Warren | Officer | F-InKind | D | Common Stock | 6,224 | 0.00 | — | 84,822 | D | ↗ |
| 2024-11-15 | Olivo Alicia C | Officer | S-Sale | D | Common Stock | 5,175 | 15.36 | 79.5K | 37,129 | D | ↗ |
| 2024-11-01 | Williams Felicia | Director | A-Award | A | Restricted Stock Unit | 7,160 | 0.00 | — | 7,160 | D | ↗ |
| 2024-09-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 1,666 | 0.00 | — | 42,147 | — | ↗ |
| 2024-08-15 | Smith Christopher M | Officer | F-InKind | D | Common Stock | 33,130 | 0.00 | — | 646,302 | — | ↗ |
| 2024-08-15 | Olivo Alicia C | Officer | S-Sale | D | Common Stock | 1,040 | 16.05 | 16.7K | 43,813 | — | ↗ |
| 2024-08-10 | Zook Anthony P. | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | TETRAULT LYNN A. | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | Perez David Brian | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | Kelly Michael Aaron | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | KANOVSKY STEPHEN M | Director | M-Exempt | A | Common Stock | 11,336 | 0.00 | — | 36,090 | — | ↗ |
| 2024-08-10 | HANNAH ALISON L. | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | Gunn Neil | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-10 | Floegel Elizabeth | Director | M-Exempt | D | Restricted Stock Unit | 11,336 | 0.00 | — | 0 | — | ↗ |
| 2024-08-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 14 | 0.00 | — | 44,853 | — | ↗ |
| 2024-06-01 | Zook Anthony P. | Director | A-Award | A | Restricted Stock Unit | 12,254 | 0.00 | — | 12,254 | — | ↗ |
| 2024-06-01 | TETRAULT LYNN A. | Director | A-Award | A | Restricted Stock Unit | 12,254 | 0.00 | — | 12,254 | — | ↗ |
| 2024-06-01 | Perez David Brian | Director | A-Award | A | Stock Option (Right to Buy) | 8,672 | 13.71 | 118.9K | 8,672 | — | ↗ |
| 2024-06-01 | Kelly Michael Aaron | Director | A-Award | A | Stock Option (Right to Buy) | 8,672 | 13.71 | 118.9K | 8,672 | — | ↗ |
| 2024-06-01 | KANOVSKY STEPHEN M | Director | A-Award | A | Restricted Stock Unit | 12,254 | 0.00 | — | 12,254 | — | ↗ |
| 2024-06-01 | HANNAH ALISON L. | Director | A-Award | A | Stock Option (Right to Buy) | 8,672 | 13.71 | 118.9K | 8,672 | — | ↗ |
| 2024-06-01 | Gunn Neil | Director | A-Award | A | Stock Option (Right to Buy) | 8,672 | 13.71 | 118.9K | 8,672 | — | ↗ |
| 2024-06-01 | Floegel Elizabeth | Director | A-Award | A | Stock Option (Right to Buy) | 8,672 | 13.71 | 118.9K | 8,672 | — | ↗ |
| 2024-05-15 | Olivo Alicia C | Officer | S-Sale | D | Common Stock | 1,049 | 15.74 | 16.5K | 44,867 | — | ↗ |
| 2024-05-11 | Stone Warren | Officer | M-Exempt | D | Restricted Stock Unit | 9,612 | 0.00 | — | 19,226 | — | ↗ |
| 2024-05-11 | Smith Christopher M | Officer | M-Exempt | D | Restricted Stock Unit | 48,063 | 0.00 | — | 96,127 | — | ↗ |
| 2024-05-11 | Sherman Jeffrey Scott | Officer | M-Exempt | D | Restricted Stock Unit | 13,005 | 0.00 | — | 26,011 | — | ↗ |
| 2024-05-11 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 1,584 | 14.86 | 23.5K | 39,414 | — | ↗ |
| 2024-05-11 | Harris Melody | Officer | M-Exempt | D | Restricted Stock Unit | 7,068 | 0.00 | — | 14,136 | — | ↗ |
| 2024-05-02 | Stone Warren | Officer | A-Award | A | Performance Stock Unit | 17,908 | 0.00 | — | 17,908 | — | ↗ |
| 2024-05-02 | Harris Melody | Officer | A-Award | A | Stock Option (Right to Buy) | 19,984 | 13.96 | 279.0K | 19,984 | — | ↗ |
| 2024-05-02 | Aunan Greg D | Officer | A-Award | A | Restricted Stock Unit | 16,117 | 0.00 | — | 16,117 | — | ↗ |
| 2024-05-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 652 | 0.00 | — | 34,496 | — | ↗ |
| 2024-05-01 | Aunan Greg D | Officer | F-InKind | D | Common Stock | 937 | 0.00 | — | 14,453 | — | ↗ |
| 2024-03-04 | TETRAULT LYNN A. | Director | S-Sale | D | Common Stock | 6,112 | 15.97 | 97.6K | 50,062 | — | ↗ |
| 2024-02-23 | Stone Warren | Officer | A-Award | A | Stock Option (Right to Buy) | 42,344 | 16.45 | 696.6K | 42,344 | — | ↗ |
| 2024-02-23 | Smith Christopher M | Officer | A-Award | A | Restricted Stock Unit | 172,239 | 0.00 | — | 172,239 | — | ↗ |
| 2024-02-23 | Sikri Vishal | Officer | A-Award | A | Stock Option (Right to Buy) | 42,344 | 16.45 | 696.6K | 42,344 | — | ↗ |
| 2024-02-23 | Sherman Jeffrey Scott | Officer | A-Award | A | Performance Stock Unit | 46,606 | 0.00 | — | 46,606 | — | ↗ |
| 2024-02-23 | Olivo Alicia C | Officer | A-Award | A | Restricted Stock Unit | 25,329 | 0.00 | — | 25,329 | — | ↗ |
| 2024-02-23 | Harris Melody | Officer | A-Award | A | Restricted Stock Unit | 25,329 | 0.00 | — | 25,329 | — | ↗ |
| 2024-02-15 | Olivo Alicia C | Officer | S-Sale | D | Common Stock | 2,587 | 14.96 | 38.7K | 34,866 | — | ↗ |
| 2024-01-01 | Harris Melody | Officer | F-InKind | D | Common Stock | 7,123 | 0.00 | — | 102,955 | — | ↗ |
| 2023-12-07 | Sherman Jeffrey Scott | Officer | F-InKind | D | Common Stock | 8,147 | 0.00 | — | 125,662 | — | ↗ |
| 2023-12-01 | Stone Warren | Officer | F-InKind | D | Common Stock | 5,431 | 0.00 | — | 83,775 | — | ↗ |
| 2023-11-17 | Olivo Alicia C | Officer | S-Sale | D | Common Stock | 2,669 | 18.39 | 49.1K | 37,140 | — | ↗ |
| 2023-09-30 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 14 | 0.00 | — | 39,498 | — | ↗ |
| 2023-09-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 1,666 | 0.00 | — | 39,411 | — | ↗ |
| 2023-08-10 | Zook Anthony P. | Director | A-Award | A | Stock Option (Right to Buy) | 8,353 | 14.82 | 123.8K | 8,353 | — | ↗ |
| 2023-08-10 | TETRAULT LYNN A. | Director | A-Award | A | Restricted Stock Unit | 11,336 | 0.00 | — | 11,336 | — | ↗ |
| 2023-08-10 | Perez David Brian | Director | A-Award | A | Stock Option (Right to Buy) | 8,353 | 14.82 | 123.8K | 8,353 | — | ↗ |
| 2023-08-10 | Kelly Michael Aaron | Director | A-Award | A | Restricted Stock Unit | 11,336 | 0.00 | — | 11,336 | — | ↗ |
| 2023-08-10 | KANOVSKY STEPHEN M | Director | A-Award | A | Stock Option (Right to Buy) | 8,353 | 14.82 | 123.8K | 8,353 | — | ↗ |
| 2023-08-10 | HANNAH ALISON L. | Director | A-Award | A | Stock Option (Right to Buy) | 8,353 | 14.82 | 123.8K | 8,353 | — | ↗ |
| 2023-08-10 | Gunn Neil | Director | A-Award | A | Restricted Stock Unit | 11,336 | 0.00 | — | 11,336 | — | ↗ |
| 2023-08-10 | Floegel Elizabeth | Director | A-Award | A | Restricted Stock Unit | 11,336 | 0.00 | — | 11,336 | — | ↗ |
| 2023-08-10 | CROWTHER BRUCE K | Director | A-Award | A | Stock Option (Right to Buy) | 8,353 | 14.82 | 123.8K | 8,353 | — | ↗ |
| 2023-08-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 14 | 0.00 | — | 40,981 | — | ↗ |
| 2023-06-26 | Zook Anthony P. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-26 | Gunn Neil | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-26 | Floegel Elizabeth | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Sikri Vishal | Officer | F-InKind | D | Common Stock | 21,406 | 0.00 | — | 127,716 | — | ↗ |
| 2023-05-22 | TETRAULT LYNN A. | Director | M-Exempt | A | Common Stock | 1,507 | 11.60 | 17.5K | 56,174 | — | ↗ |
| 2023-05-15 | Aunan Greg D | Officer | — | D | Stock Option (Right to Buy) | 28,662 | 14.62 | 419.0K | 0 | — | ↗ |
| 2023-05-11 | Stone Warren | Officer | A-Award | A | Performance Stock Unit | 21,204 | 0.00 | — | 21,204 | — | ↗ |
| 2023-05-11 | Smith Christopher M | Officer | A-Award | A | Performance Stock Unit | 144,190 | 0.00 | — | 144,190 | — | ↗ |
| 2023-05-11 | Sikri Vishal | Officer | A-Award | A | Performance Stock Unit | 21,204 | 0.00 | — | 21,204 | — | ↗ |
| 2023-05-11 | Sherman Jeffrey Scott | Officer | A-Award | A | Performance Stock Unit | 39,016 | 0.00 | — | 39,016 | — | ↗ |
| 2023-05-11 | Olivo Alicia C | Officer | A-Award | A | Stock Option (Right to Buy) | 36,508 | 19.65 | 717.4K | 36,508 | — | ↗ |
| 2023-05-11 | Harris Melody | Officer | A-Award | A | Performance Stock Unit | 21,204 | 0.00 | — | 21,204 | — | ↗ |
| 2023-05-01 | Olivo Alicia C | Officer | F-InKind | D | Common Stock | 662 | 0.00 | — | 40,694 | — | ↗ |
| 2023-04-01 | Kulkarni Shashikant | Officer | F-InKind | D | Common Stock | 3,759 | 0.00 | — | 82,673 | — | ↗ |
| 2023-03-02 | Dieter Cynthia J | Officer | F-InKind | D | Common Stock | 117 | 0.00 | — | 29,765 | — | ↗ |
| 2023-03-01 | Dieter Cynthia J | Officer | F-InKind | D | Common Stock | 880 | 0.00 | — | 29,882 | — | ↗ |
| 2023-01-01 | Harris Melody | Officer | A-Award | A | Stock Option (Right to Buy) | 201,613 | 0.00 | — | 201,613 | — | ↗ |
| 2022-12-31 | Sikri Vishal | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Dieter Cynthia J | Officer | F-InKind | D | Common Stock | 959 | 0.00 | — | 30,762 | — | ↗ |
| 2022-12-05 | Sherman Jeffrey Scott | Officer | A-Award | A | Common Stock | 44,603 | 0.00 | — | 44,603 | — | ↗ |
| 2022-12-05 | Harris Melody | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-01 | Stone Warren | Officer | A-Award | A | Stock Option (Right to Buy) | 166,113 | 0.00 | — | 166,113 | — | ↗ |
| 2022-11-21 | Stone Warren | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-11-03 | Perez David Brian | Director | A-Award | A | Stock Option (Right to Buy) | 9,730 | 0.00 | — | 9,730 | — | ↗ |
| 2022-11-01 | Dieter Cynthia J | Officer | A-Award | A | Common Stock | 13,141 | 0.00 | — | 31,721 | — | ↗ |
| 2022-10-18 | Olivo Alicia C | Officer | — | D | Stock Option (Right to Buy) | 55,332 | 10.05 | 556.1K | — | — | ↗ |
| 2022-08-15 | Smith Christopher M | Officer | A-Award | A | Stock Option (Right to Buy) | 694,444 | 0.00 | — | 694,444 | — | ↗ |
| 2022-08-01 | Sholehvar David | Officer | A-Award | A | Stock Option (Right to Buy) | 25,826 | 0.00 | — | 25,826 | — | ↗ |
| 2022-08-01 | Kulkarni Shashikant | Officer | A-Award | A | Common Stock | 24,704 | 0.00 | — | 65,856 | — | ↗ |
| 2022-07-07 | Kulkarni Shashikant | Officer | — | D | Common Stock | 0 | 0.00 | — | 61,728 | — | ↗ |
| 2022-06-22 | Dieter Cynthia J | Officer | F-InKind | D | Common Stock | 57 | 0.00 | — | 18,580 | — | ↗ |
| 2022-06-10 | TETRAULT LYNN A. | Director | A-Award | A | Common Stock | 15,556 | 0.00 | — | 54,667 | — | ↗ |
| 2022-06-10 | Stahler Rachel A | Director | A-Award | A | Common Stock | 15,556 | 0.00 | — | 21,335 | — | ↗ |
| 2022-06-10 | Kelly Michael Aaron | Director | A-Award | A | Stock Option (Right to Buy) | 13,882 | 0.00 | — | 13,882 | — | ↗ |
| 2022-06-10 | KANOVSKY STEPHEN M | Director | A-Award | A | Common Stock | 15,556 | 0.00 | — | 24,754 | — | ↗ |
| 2022-06-10 | HANNAH ALISON L. | Director | A-Award | A | Stock Option (Right to Buy) | 13,882 | 8.10 | 112.4K | 13,882 | — | ↗ |
| 2022-06-10 | Daly David | Director | A-Award | A | Common Stock | 15,556 | 0.00 | — | 17,179 | — | ↗ |
| 2022-06-10 | CROWTHER BRUCE K | Director | A-Award | A | Stock Option (Right to Buy) | 13,882 | 8.10 | 112.4K | 13,882 | — | ↗ |
| 2022-06-01 | Sikri Vishal | Officer | A-Award | A | Stock Option (Right to Buy) | 319,112 | 0.00 | — | 319,112 | — | ↗ |
| 2022-05-23 | Sikri Vishal | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-18 | TETRAULT LYNN A. | Director | M-Exempt | A | Common Stock | 3,334 | 7.27 | 24.2K | 39,111 | — | ↗ |
| 2022-04-28 | Bonello William | Officer | M-Exempt | A | Common Stock | 5,727 | 7.52 | 43.1K | 191,548 | — | ↗ |
| 2022-04-01 | Sholehvar David | Officer | A-Award | A | Stock Option (Right to Buy) | 66,372 | 0.00 | — | 66,372 | — | ↗ |
| 2022-04-01 | Brown Douglas Matthew | Officer | A-Award | A | Common Stock | 82,305 | 0.00 | — | 158,684 | — | ↗ |
| 2022-04-01 | Bonello William | Officer | A-Award | A | Common Stock | 82,305 | 0.00 | — | 185,821 | — | ↗ |
| 2022-03-14 | Sholehvar David | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-08 | Bonello William | Officer | M-Exempt | A | Common Stock | 5,000 | 7.52 | 37.6K | 103,516 | — | ↗ |
| 2022-03-07 | Bonello William | Officer | S-Sale | D | Common Stock | 3,209 | 18.29 | 58.7K | 98,516 | — | ↗ |
| 2022-03-02 | Dieter Cynthia J | Officer | F-InKind | D | Common Stock | 137 | 0.00 | — | 18,637 | — | ↗ |
| 2022-03-02 | Bonello William | Officer | F-InKind | D | Common Stock | 620 | 0.00 | — | 101,725 | — | ↗ |
| 2022-03-01 | Wallar Gina M | Officer | A-Award | A | Common Stock | 11,677 | 0.00 | — | 33,443 | — | ↗ |
| 2022-03-01 | Mallon Mark | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 347,777 | 21.41 | 7.45M | 347,777 | — | ↗ |
| 2022-03-01 | Gilbert Halley E | Officer | A-Award | A | Stock Option (Right to Buy) | 102,623 | 21.41 | 2.20M | 102,623 | — | ↗ |
| 2022-03-01 | Dieter Cynthia J | Officer | A-Award | A | Common Stock | 9,341 | 0.00 | — | 18,774 | — | ↗ |
| 2022-03-01 | CARDOZA GEORGE | Officer | F-InKind | D | Common Stock | 839 | 0.00 | — | 244,157 | — | ↗ |
| 2022-03-01 | Brown Douglas Matthew | Officer | F-InKind | D | Common Stock | 867 | 0.00 | — | 76,379 | — | ↗ |
| 2022-03-01 | Bonello William | Officer | A-Award | A | Stock Option (Right to Buy) | 99,772 | 0.00 | — | 99,772 | — | ↗ |
| 2022-01-11 | McKenzie Kathryn B | Officer | M-Exempt | A | Common Stock | 2,100 | 9.07 | 19.0K | 49,361 | — | ↗ |
| 2021-12-31 | Wallar Gina M | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-48.4K
Shares Outstanding
26.04M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Tony Zook Director and Chief Executive Officer | 601.5K | — | 4.00M | 4.00M | 513.4K | 13.9K | 9.13M | 87.63% | ↗ |
| 2 | 2025 | Warren Stone Chief Commercial Officer | 630.1K | 400.0K | 2.25M | 1.50M | 275.0K | 14.0K | 5.07M | 73.98% | ↗ |
| 3 | 2025 | Jeffrey Sherman Chief Financial Officer | 603.7K | 50.0K | 2.25M | 1.50M | 264.0K | 14.0K | 4.68M | 80.10% | ↗ |
| 4 | 2025 | Christopher Smith Former Director and Former Chief Executive Officer | 311.0K | — | 3.35M | — | 155.8K | 229.2K | 4.05M | 82.80% | ↗ |
| 5 | 2025 | M elody Harris Former Chief Operations Officer and Former President, Oncology Data Solutions | 269.2K | 152.3K | 1.67M | 912.8K | — | 691.4K | 3.69M | 69.86% | ↗ |
| 6 | 2025 | Alicia Olivo Executive Vice President, General Counsel and Business Development | 522.5K | 75.0K | 1.50M | 749.8K | 196.0K | 6.7K | 3.05M | 73.77% | ↗ |
| 7 | 2025 | Gary Passman Chief Culture Officer | 448.0K | 75.0K | 1.12M | 624.9K | 164.0K | 6.4K | 2.44M | 71.62% | ↗ |
| 8 | 2024 | Christopher Smith Former Director and Former Chief Executive Officer | 1.04M | — | 5.87M | 2.83M | 1.59M | 13.8K | 11.34M | 76.71% | ↗ |
| 9 | 2024 | Christopher M. Smith Director and Chief Executive Officer | 1.04M | — | 5.87M | 2.83M | 1.59M | 13.8K | 11.34M | 76.71% | ↗ |
| 10 | 2024 | Jeffrey S. Sherman Chief Financial Officer | 540.3K | — | 1.59M | 764.5K | 575.2K | 13.8K | 3.48M | 67.57% | ↗ |
| 11 | 2024 | Jeffrey Sherman Chief Financial Officer | 540.3K | — | 1.59M | 764.5K | 575.2K | 13.8K | 3.48M | 67.57% | ↗ |
| 12 | 2024 | Warren Stone Chief Commercial Officer | 562.5K | — | 1.38M | 665.3K | 561.7K | 13.8K | 3.18M | 64.26% | ↗ |
| 13 | 2024 | Warren C. Stone Chief Commercial Officer | 562.5K | — | 1.38M | 665.3K | 561.7K | 13.8K | 3.18M | 64.26% | ↗ |
| 14 | 2024 | Melody Harris Chief Operations Officer and President, Oncology Data Solutions | 560.0K | — | 1.21M | 582.4K | 510.6K | 13.8K | 2.88M | 62.29% | ↗ |
| 15 | 2024 | M elody Harris Former Chief Operations Officer and Former President, Oncology Data Solutions | 560.0K | — | 1.21M | 582.4K | 510.6K | 13.8K | 2.88M | 62.29% | ↗ |
| 16 | 2024 | Vishal Sikri President, Advanced Diagnostics | 246.2K | — | 941.9K | 457.4K | — | 636.9K | 2.28M | 61.31% | ↗ |
| 17 | 2024 | Alicia C. Olivo Executive Vice President, General Counsel and Business Development | 512.7K | — | 863.4K | 415.3K | 431.8K | 13.8K | 2.24M | 57.16% | ↗ |
| 18 | 2024 | Alicia Olivo Executive Vice President, General Counsel and Business Development | 512.7K | — | 863.4K | 415.3K | 431.8K | 13.8K | 2.24M | 57.16% | ↗ |
| 19 | 2023 | Christopher M. Smith Director and Chief Executive Officer | 1.00M | — | 5.99M | 2.82M | 1.85M | 12.3K | 11.67M | 75.46% | ↗ |
| 20 | 2023 | Christopher Smith Former Director and Former Chief Executive Officer | 1.00M | — | 5.99M | 2.82M | 1.85M | 12.3K | 11.67M | 75.46% | ↗ |
| 21 | 2023 | Christopher Smith Director and Chief Executive Officer | 1.00M | — | 5.99M | 2.82M | 1.85M | 12.3K | 11.67M | 75.46% | ↗ |
| 22 | 2023 | Melody Harris Chief Operations Officer and President, Oncology Data Solutions | 525.0K | — | 1.88M | 1.41M | 532.7K | 342.6K | 4.69M | 70.17% | ↗ |
| 23 | 2023 | Melody Harris President, Enterprise Operations | 525.0K | — | 1.88M | 1.41M | 532.7K | 342.6K | 4.69M | 70.17% | ↗ |
| 24 | 2023 | M elody Harris Former Chief Operations Officer and Former President, Oncology Data Solutions | 525.0K | — | 1.88M | 1.41M | 532.7K | 342.6K | 4.69M | 70.17% | ↗ |
| 25 | 2023 | Jeffrey S. Sherman Chief Financial Officer | 525.0K | — | 1.62M | 762.2K | 627.0K | 13.2K | 3.55M | 67.15% | ↗ |
| 26 | 2023 | Jeffrey Sherman Chief Financial Officer | 525.0K | — | 1.62M | 762.2K | 627.0K | 13.2K | 3.55M | 67.15% | ↗ |
| 27 | 2023 | Warren C. Stone Chief Commercial Officer | 525.0K | — | 1.03M | 563.4K | 546.8K | 343.7K | 3.01M | 52.96% | ↗ |
| 28 | 2023 | Warren Stone Chief Commercial Officer | 525.0K | — | 1.03M | 563.4K | 546.8K | 343.7K | 3.01M | 52.96% | ↗ |
| 29 | 2023 | Warren Stone President, Clinical Services | 525.0K | — | 1.03M | 563.4K | 546.8K | 343.7K | 3.01M | 52.96% | ↗ |
| 30 | 2023 | Vishal Sikri President, Advanced Diagnostics | 528.6K | — | 880.4K | 414.3K | 535.3K | 13.2K | 2.37M | 54.59% | ↗ |
| 31 | 2022 | Christopher M. Smith Director and Chief Executive Officer | 346.2K | — | 7.60M | 4.25M | 455.4K | 2.15M | 14.80M | 80.08% | ↗ |
| 32 | 2022 | Christopher Smith Director and Chief Executive Officer | 346.2K | — | 7.60M | 4.25M | 455.4K | 2.15M | 14.80M | 80.08% | ↗ |
| 33 | 2022 | Mark Mallon Former Director and Former Chief Executive Officer | 171.3K | — | 3.66M | 2.29M | — | 1.58M | 7.70M | 77.28% | ↗ |
| 34 | 2022 | Vishal Sikri President, Advanced Diagnostics | 294.2K | 500.0K | 1.25M | 1.25M | 255.0K | 12.8K | 3.56M | 70.19% | ↗ |
| 35 | 2022 | Jeffrey S. Sherman Chief Financial Officer | 16.2K | 250.0K | 1.50M | 1.50M | — | — | 3.27M | 91.85% | ↗ |
| 36 | 2022 | Jeffrey Sherman Chief Financial Officer | 16.2K | 250.0K | 1.50M | 1.50M | — | — | 3.27M | 91.85% | ↗ |
| 37 | 2022 | Dr. Shashikant Kulkarni Chief Scientific Officer and Executive Vice President of Research & Development | 354.8K | 100.0K | 1.00M | 1.00M | 187.4K | 27.0K | 2.67M | 74.93% | ↗ |
| 38 | 2022 | Warren Stone President, Clinical Services | 40.4K | 350.0K | 1.00M | 1.00M | — | — | 2.39M | 83.67% | ↗ |
| 39 | 2022 | Warren C. Stone Chief Commercial Officer | 40.4K | 350.0K | 1.00M | 1.00M | — | — | 2.39M | 83.67% | ↗ |
| 40 | 2022 | Lynn Tetrault Former Interim Chief Executive Officer and Current Chair of the Board of Directors | 391.2K | — | 126.0K | 54.0K | 1.50M | — | 2.07M | 8.69% | ↗ |
| 41 | 2022 | William Bonello Former Chief Financial Officer | 462.1K | — | 330.8K | 77.0K | — | 682.5K | 1.55M | 26.27% | ↗ |
| 42 | 2021 | Mark W. Mallon Director and Chief Executive Officer | 488.0K | — | 7.75M | 2.75M | 407.9K | 84.0K | 11.48M | 91.46% | ↗ |
| 43 | 2021 | Mark Mallon Former Director and Former Chief Executive Officer | 488.0K | — | 7.75M | 2.75M | — | 84.0K | 11.07M | 94.83% | ↗ |
| 44 | 2021 | Douglas M. VanOort Former Chair of the Board and Former Chief Executive Officer | 649.3K | — | 1.67M | 4.91M | — | — | 7.23M | 91.02% | ↗ |
| 45 | 2021 | Halley E. Gilbert Chief Legal Officer and Corporate Secretary | 160.9K | 100.0K | 4.00M | 1.00M | 84.5K | 100.0K | 5.45M | 91.82% | ↗ |
| 46 | 2021 | George A. Cardoza President and Chief Operating Officer, Laboratory Operations, Clinical Services | 447.5K | 100.0K | 2.66M | 1.34M | 242.6K | 10.4K | 4.80M | 83.32% | ↗ |
| 47 | 2021 | Dr. Clive D. Morris President, Inivata | 299.4K | 100.0K | 1.47M | 933.3K | 296.9K | 30.2K | 3.13M | 76.76% | ↗ |
| 48 | 2021 | Kathryn B. McKenzie Chief Financial Officer | 415.4K | 200.0K | 1.33M | 670.0K | 166.5K | 11.6K | 2.79M | 71.60% | ↗ |
| 49 | 2020 | Douglas M. VanOort Chairman of the Board & Chief Executive Officer | 669.0K | — | 990.0K | 2.01M | 450.0K | 3.0K | 4.12M | 72.78% | ↗ |
| 50 | 2020 | Douglas M. VanOort Former Chair of the Board and Former Chief Executive Officer | 669.0K | — | 990.0K | 2.01M | 450.0K | — | 4.12M | 72.83% | ↗ |
| 51 | 2020 | Robert J. Shovlin President of Clinical Services | 404.8K | — | 247.5K | 502.0K | 140.0K | 3.0K | 1.30M | 57.77% | ↗ |
| 52 | 2020 | Dr. Lawrence M. Weiss Chief Medical Officer | 600.0K | — | 165.0K | 335.0K | 185.0K | — | 1.29M | 38.91% | ↗ |
| 53 | 2020 | Douglas M. Brown Chief Strategy and Corporate Development Officer | 346.2K | — | 198.0K | 402.0K | 200.0K | 100.0K | 1.25M | 48.15% | ↗ |
| 54 | 2020 | George A. Cardoza President and Chief Operating Officer, Laboratory Operations, Clinical Services | 384.6K | — | 214.5K | 435.5K | 155.0K | — | 1.19M | 54.64% | ↗ |
| 55 | 2020 | Kathryn B. McKenzie Chief Financial Officer | 359.6K | — | 165.0K | 335.0K | 175.0K | — | 1.03M | 48.33% | ↗ |
| 56 | 2019 | Douglas M. VanOort Chairman of the Board & Chief Executive Officer | 665.0K | — | 742.5K | 1.34M | 900.0K | 3.0K | 3.65M | 57.03% | ↗ |
| 57 | 2019 | Douglas M. VanOort Former Chair of the Board and Former Chief Executive Officer | 665.0K | — | 742.5K | 1.34M | 900.0K | — | 3.65M | 57.07% | ↗ |
| 58 | 2019 | Robert J. Shovlin President of Clinical Services | 400.0K | — | 214.5K | 386.6K | 280.0K | 3.0K | 1.28M | 46.81% | ↗ |
| 59 | 2019 | Lawrence M. Weiss Chief Medical Officer | 600.0K | — | 115.5K | 208.2K | 260.0K | — | 1.18M | 27.34% | ↗ |
| 60 | 2019 | Dr. Lawrence M. Weiss Chief Medical Officer | 600.0K | — | 115.5K | 208.2K | 260.0K | — | 1.18M | 27.34% | ↗ |
| 61 | 2019 | George A. Cardoza President and Chief Operating Officer, Laboratory Operations, Clinical Services | 380.0K | — | 165.0K | 297.4K | 265.0K | — | 1.11M | 41.75% | ↗ |
| 62 | 2019 | George A. Cardoza President of Pharma Services | 380.0K | — | 165.0K | 297.4K | 265.0K | — | 1.11M | 41.75% | ↗ |
| 63 | 2019 | Sharon A. Virag Chief Financial Officer | 257.7K | — | 214.5K | 386.6K | 182.8K | — | 1.04M | 57.71% | ↗ |
| 64 | 2019 | Kathryn B. McKenzie Chief Financial Officer | 250.0K | — | 44.6K | 80.3K | 150.0K | — | 524.8K | 23.79% | ↗ |
| 65 | 2019 | Kathryn B. McKenzie Vice President and Chief Accounting Officer (Principal Financial Officer) | 250.0K | — | 44.6K | 80.3K | 150.0K | — | 524.8K | 23.79% | ↗ |
| 66 | 2018 | Douglas M. VanOort Chairman of the Board & Chief Executive Officer | 641.9K | — | 650.0K | 1.28M | 774.0K | 3.0K | 3.35M | 57.61% | ↗ |
| 67 | 2018 | Douglas M. VanOort Chief Executive Officer & Chairman of the Board | 641.9K | — | 650.0K | 1.28M | 774.0K | 3.0K | 3.35M | 57.61% | ↗ |
| 68 | 2018 | Robert J. Shovlin President of Clinical Services | 375.4K | — | — | 737.6K | 212.8K | 3.0K | 1.33M | 55.51% | ↗ |
| 69 | 2018 | Sharon A. Virag Chief Financial Officer | 298.5K | 120.0K | — | 485.1K | 190.0K | — | 1.09M | 44.36% | ↗ |
| 70 | 2018 | George A. Cardoza President of Pharma Services | 370.0K | — | — | 492.2K | 194.4K | — | 1.06M | 46.58% | ↗ |
| 71 | 2018 | Dr. Lawrence M. Weiss Chief Medical Officer | 571.5K | 100.0K | — | 152.1K | 32.3K | — | 855.9K | 17.77% | ↗ |
| 72 | 2018 | Lawrence M. Weiss Chief Medical Officer | 571.5K | 100.0K | — | 152.1K | 32.3K | — | 855.9K | 17.77% | ↗ |
| 73 | 2018 | Lawrence M. Weiss Chief Scientific Officer | 571.5K | 100.0K | — | 152.1K | 32.3K | — | 855.9K | 17.77% | ↗ |
| 74 | 2018 | William B. Bonello Chief Strategy and Corp Development Officer Director, Investor Relations | 337.7K | — | — | 308.1K | 174.4K | — | 820.1K | 37.56% | ↗ |
| 75 | 2017 | Douglas M. VanOort Chairman of the Board & Chief Executive Officer | 616.3K | — | 1.43M | 1.23M | 200.0K | 3.0K | 3.48M | 76.48% | ↗ |
| 76 | 2017 | Douglas M. VanOort Chief Executive Officer & Chairman of the Board | 616.3K | — | 1.43M | 1.23M | 200.0K | 3.0K | 3.48M | 76.48% | ↗ |
| 77 | 2017 | Maher Albitar, MD Chief Medical Officer | — | — | 145.4K | 492.7K | 106.6K | 600.0K | 1.34M | 47.45% | ↗ |
| 78 | 2017 | Robert J. Shovlin President of Clinical Services | 350.0K | — | 363.5K | 492.7K | 95.0K | 3.0K | 1.30M | 65.65% | ↗ |
| 79 | 2017 | George A. Cardoza President of Pharma Services | 352.7K | — | 181.8K | 492.7K | 80.0K | — | 1.11M | 60.92% | ↗ |
| 80 | 2017 | George A. Cardoza Chief Financial Officer | 352.7K | — | 181.8K | 492.7K | 80.0K | — | 1.11M | 60.92% | ↗ |
| 81 | 2017 | Steven G. Brodie, PHD Vice President of Operations | 335.0K | — | — | 123.2K | 47.5K | — | 505.7K | 24.36% | ↗ |
| 82 | 2016 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 600.0K | — | — | 1.18M | 311.0K | 26.1K | 2.12M | 55.78% | ↗ |
| 83 | 2016 | Douglas M. VanOort Chief Executive Officer & Chairman of the Board | 600.0K | — | — | 1.18M | 311.0K | 26.1K | 2.12M | 55.78% | ↗ |
| 84 | 2016 | Dr. Maher Albitar Chief Medical Officer | — | — | — | 500.3K | 195.7K | 571.9K | 1.27M | 39.46% | ↗ |
| 85 | 2016 | Maher Albitar, MD Chief Medical Officer | — | — | — | 500.3K | 195.7K | 571.9K | 1.27M | 39.46% | ↗ |
| 86 | 2016 | Robert J. Shovlin President of Clinical Services | 336.0K | — | — | 500.3K | 115.0K | 9.7K | 961.0K | 52.06% | ↗ |
| 87 | 2016 | George A. Cardoza Chief Financial Officer | 293.1K | — | — | 500.3K | 120.0K | — | 913.4K | 54.77% | ↗ |
| 88 | 2016 | George A. Cardoza President of Pharma Services | 293.1K | — | — | 500.3K | 120.0K | — | 913.4K | 54.77% | ↗ |
| 89 | 2016 | Steven G. Brodie, PHD Vice President of Operations | 313.7K | — | — | 250.1K | 45.0K | 12.9K | 621.7K | 40.24% | ↗ |
| 90 | 2016 | Steven G. Brodie Vice President Of Operations | 313.7K | — | — | 250.1K | 45.0K | 12.9K | 621.7K | 40.24% | ↗ |
| 91 | 2015 | Dr. Maher Albitar Chief Medical Officer | — | — | — | 1.18M | 150.0K | 460.0K | 1.79M | 65.99% | ↗ |
| 92 | 2015 | Maher Albitar, MD Chief Medical Officer | — | — | — | 1.18M | 150.0K | 460.0K | 1.79M | 65.99% | ↗ |
| 93 | 2015 | Steven C. Jones Executive Vice President, Finance | — | 500.0K | — | 866.2K | 78.9K | 261.8K | 1.71M | 50.75% | ↗ |
| 94 | 2015 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 475.0K | 600.0K | — | — | 206.4K | 1.4K | 1.28M | 0.00% | ↗ |
| 95 | 2015 | Douglas M. VanOort Chief Executive Officer & Chairman of the Board | 475.0K | 600.0K | — | — | 206.4K | 1.4K | 1.28M | 0.00% | ↗ |
| 96 | 2015 | George A. Cardoza Chief Financial Officer | 270.0K | 100.0K | — | 359.7K | 80.9K | — | 810.7K | 44.38% | ↗ |
| 97 | 2015 | Steven G. Brodie, PHD Vice President of Operations | 305.7K | — | — | 215.8K | 51.4K | — | 573.0K | 37.67% | ↗ |
| 98 | 2015 | Steven G. Brodie Vice President Of Operations | 305.7K | — | — | 215.8K | 51.4K | — | 573.0K | 37.67% | ↗ |
| 99 | 2015 | Steven A. Ross Chief Information Officer | 256.8K | — | — | 179.9K | 70.0K | 1.4K | 508.0K | 35.41% | ↗ |
| 100 | 2015 | Robert J. Shovlin President of Clinical Services | 331.3K | — | — | — | 100.0K | 9.8K | 441.1K | 0.00% | ↗ |
| 101 | 2015 | Robert J. Shovlin Chief Growth Officer | 331.3K | — | — | — | 100.0K | 9.8K | 441.1K | 0.00% | ↗ |
| 102 | 2014 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 441.3K | — | 381.3K | — | 305.2K | — | 1.13M | 33.81% | ↗ |
| 103 | 2014 | Dr. Maher Albitar Chief Medical Officer | — | — | — | 75.6K | 141.3K | 453.1K | 670.0K | 11.29% | ↗ |
| 104 | 2014 | Robert J. Shovlin Chief Growth Officer | 68.8K | — | — | 502.9K | 21.5K | — | 593.1K | 84.79% | ↗ |
| 105 | 2014 | Robert J. Shovlin President of Clinical Services | 68.8K | — | — | 502.9K | 21.5K | — | 593.1K | 84.79% | ↗ |
| 106 | 2014 | Steven C. Jones Executive Vice President, Finance | — | 100.0K | — | — | 77.5K | 257.5K | 435.0K | 0.00% | ↗ |
| 107 | 2014 | George A. Cardoza Chief Financial Officer | 266.5K | — | — | 34.6K | 84.3K | — | 385.4K | 8.98% | ↗ |
| 108 | 2014 | Steven G. Brodie Vice President Of Operations | 276.0K | — | — | 23.1K | 40.6K | — | 339.6K | 6.79% | ↗ |
| 109 | 2014 | Steven A. Ross Chief Information Officer | 254.3K | — | — | — | 74.4K | — | 328.7K | 0.00% | ↗ |
| 110 | 2014 | Robert J. Shovlin Chief Operating Officer | 68.8K | 20.0K | — | 59.9K | 1.5K | — | 150.1K | 39.90% | ↗ |
| 111 | 2013 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 425.0K | — | — | — | 139.4K | — | 564.4K | 0.00% | ↗ |
| 112 | 2013 | Dr. Maher Albitar Chief Medical Officer | — | — | — | — | 100.1K | 435.4K | 535.5K | 0.00% | ↗ |
| 113 | 2013 | Steven A. Ross Chief Information Officer | 156.9K | — | — | 192.3K | 32.6K | 24.8K | 406.6K | 47.28% | ↗ |
| 114 | 2013 | Robert P. Gasparini Chief Scientific Officer | 286.6K | 45.0K | — | — | 4.9K | — | 336.5K | 0.00% | ↗ |
| 115 | 2013 | Steven C. Jones Executive Vice President, Finance | — | 25.0K | — | — | 51.9K | 250.0K | 326.9K | 0.00% | ↗ |
| 116 | 2013 | George A. Cardoza Chief Financial Officer | 245.5K | — | — | — | 64.3K | — | 309.8K | 0.00% | ↗ |
| 117 | 2012 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 410.0K | 203.0K | — | 235.5K | — | — | 848.5K | 27.75% | ↗ |
| 118 | 2012 | Dr. Maher Albitar Chief Medical Officer | — | 98.8K | — | 286.3K | — | 405.0K | 790.1K | 36.24% | ↗ |
| 119 | 2012 | Robert P. Gasparini Chief Scientific Officer | 282.4K | 69.5K | — | — | — | — | 351.9K | 0.00% | ↗ |
| 120 | 2012 | George A. Cardoza Chief Financial Officer | 233.9K | 65.0K | — | 34.9K | — | — | 333.8K | 10.46% | ↗ |
| 121 | 2012 | Steven C. Jones Executive Vice President, Finance | — | 80.0K | — | — | — | 207.5K | 287.5K | 0.00% | ↗ |
| 122 | 2011 | Douglas M. VanOort Chief Executive Officer and Chairman of the Board | 325.0K | 175.0K | — | 86.3K | — | — | 586.3K | 14.72% | ↗ |
| 123 | 2011 | George A. Cardoza Chief Financial Officer | 221.4K | 65.0K | — | 56.1K | — | — | 342.6K | 16.39% | ↗ |
| 124 | 2011 | Robert P. Gasparini Chief Scientific Officer | 258.3K | 57.7K | — | 21.7K | — | — | 337.7K | 6.42% | ↗ |
| 125 | 2011 | Steven C. Jones Executive Vice President, Finance | — | 55.0K | — | — | — | 239.2K | 294.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anthony Zook | Chief Executive Officer & Director | 1M | male |
| Warren Stone | President & Chief Operating Officer | 1M | male |
| Alicia Olivo | Executive Vice President of Business Development, General Counsel & Corporate Secretary | 800.2K | female |
| Gary Passman | Chief People & Culture Officer | 693.3K | male |
| Elizabeth A. Floegel | Chief Digital & Information Officer | 38.6K | female |
| Abhishek Jain | Executive VP & CFO | — | male |
| Gregory D. Aunan | Senior Vice President & Chief Accounting Officer | — | male |
| Kareem Saad | Head of Strategy, Business Development & Transformation | — | male |
| Kendra Sweeney | Vice President of Investor Relations & Communications | — | female |
| Clarence Cooper | Vice President of Compliance & Privacy | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-05-07 | 2025-06-06 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2021-12-30 | 2022-01-08 | Deborah K. Ross | NC02 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2021-11-09 | 2021-11-14 | Bob Gibbs | OH07 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-03-02 | 2020-04-23 | Dwight Evans | Pa03 | Self | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NEO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
